Skip to main content
Scientific Reports logoLink to Scientific Reports
. 2022 Jan 17;12:1147. doi: 10.1038/s41598-022-05489-0

Author Correction: Impact of KRAS mutation status on the efficacy of immunotherapy in lung cancer brain metastases

Adam Lauko 1, Rupesh Kotecha 2,3, Addison Barnett 4, Hong Li 5, Vineeth Tatineni 6, Assad Ali 4, Pradnya Patil 7, Alireza M Mohammadi 1,4,8, Samuel T Chao 4,9, Erin S Murphy 4,9, Lilyana Angelov 1,4,8, John H Suh 4,9, Gene H Barnett 1,4,8, Nathan A Pennell 7, Manmeet S Ahluwalia 3,10,
PMCID: PMC8763914  PMID: 35039661

Correction to: Scientific Reports https://doi.org/10.1038/s41598-021-97566-z, published online 13 September 2021

The original version of this Article contained an error in the Funding section.

“This research received no specific grant from any funding agency in the public, commercial, or not-for-profit sectors.”

now reads:

“This work was partially funded by the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship F30CA250254 (AL).”

The original Article has been corrected.


Articles from Scientific Reports are provided here courtesy of Nature Publishing Group

RESOURCES